DealsSep 11, 2026, 04:12 PM
Park Ha Biological Technology Raises $2.97M Via PIPE
AI Summary
Park Ha Biological Technology Co., Ltd. announced a private investment in public equity (PIPE) transaction, entering into a securities purchase agreement with certain non-U.S. investors. The company agreed to issue and sell 1,080,000 Class A ordinary shares at $2.75 per share, along with warrants to purchase an additional 1,845,452 Class A ordinary shares. This transaction is expected to generate aggregate gross proceeds of approximately US$2,970,000 before deducting offering expenses. The net proceeds will be utilized for general working capital and corporate purposes.
Key Highlights
- Park Ha Biological Technology Co., Ltd. entered into a securities purchase agreement for a PIPE transaction.
- The company will issue and sell 1,080,000 Class A ordinary shares at $2.75 per share.
- Warrants to purchase 1,845,452 Class A ordinary shares will also be issued.
- Aggregate gross proceeds to the company are approximately US$2,970,000 before expenses.
- The Warrants are exercisable immediately for five years at an exercise price of US$1.1 per share.
- Net proceeds will be used for general working capital and corporate purposes.
Price Impact
More from BYAH